| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Revenue | $2.9B | $2.3B | $1.6B |
| Cost of Revenue | — | — | — |
| Gross Profit | — | — | — |
| R&D Expense | — | — | — |
| SG&A Expense | $0.3B | $0.3B | $0.3B |
| Operating Income | — | — | — |
| Net Income | $0.8B | $0.6B | $0.3B |
| EPS (Basic) | $5.75 | $3.81 | $2.47 |
| EPS (Diluted) | $5.55 | $3.67 | $2.44 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Total Assets | $9.6B | $7.8B | $6.7B |
| Current Assets | — | — | — |
| Cash & Equivalents | $1.1B | $1.0B | $0.8B |
| Total Liabilities | $6.7B | $5.5B | $4.6B |
| Current Liabilities | — | — | — |
| Stockholders' Equity | $2.8B | $2.3B | $2.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Operating Cash Flow | $0.8B | $0.8B | $0.3B |
| Investing Cash Flow | $-0.4B | $-0.2B | $-0.7B |
| Capital Expenditures | — | — | — |
| Financing Cash Flow | $-0.4B | $-0.4B | $0.1B |